Point Of Care Devices Market Report 2026

Point Of Care Devices Market Overview

• Point Of Care Devices market size has reached to $31.46 billion in 2025 • Expected to grow to $48.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Growing Demand For Diagnostic Imaging Fueling The Growth Of The Market Due To Rising Prevalence Of Chronic Diseases And Need For Rapid, Accurate Diagnosis • Market Trend: Innovative Artificial Intelligence-Powered Handheld Ultrasound Devices Elevate Diagnostic Precision • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Point Of Care Devices Market?

Point of care devices are medical diagnostic tools designed to be used at or near the site of patient care, such as clinics, hospitals, or even at home. Their primary purpose is to deliver rapid, on-the-spot test results, enabling timely clinical decisions and immediate treatment. These devices simplify complex laboratory tests, making healthcare more accessible and efficient. The main device types of point of care devices are diagnostic devices, therapeutic devices, monitoring devices, treatment devices, and support devices. Diagnostic devices are medical tools or instruments used to detect, measure, and monitor diseases or health conditions by analyzing patient samples or physiological parameters. They utilize various technologies such as biochemical technology, microfluidics, immunoassay technology, nucleic acid testing, and wearable technology and are applied in fields such as cardiology, diabetes management, infectious diseases, oncology, and pediatrics. These devices are distributed through various channels, including direct sales, distributors, online sales, retail pharmacies, and healthcare institutions, serving end users such as direct sales, distributors, online sales, retail pharmacies, and healthcare institutions.

What Is The Point Of Care Devices Market Growth Forecast?

The point of care devices market size is expected to see strong growth in the next few years. It will grow to $48.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to advancements in microfluidics and biosensors, increasing adoption of wearable and remote monitoring devices, growth in home healthcare settings, rising infectious disease surveillance needs, integration of digital health platforms. Major trends in the forecast period include rising adoption of rapid diagnostic testing at care sites, increasing demand for home-based and self-testing devices, miniaturization of diagnostic and monitoring devices, growing focus on decentralized healthcare delivery, expansion of point of care testing in emergency and critical care.

Global Point Of Care Devices Market Segmentation

1) By Type Of Device: Diagnostic Devices, Therapeutic Devices, Monitoring Devices, Treatment Devices, Support Devices 2) By Technology: Biochemical Technology, Microfluidics, Immunoassay Technology, Nucleic Acid Testing, Wearable Technology 3) By Application: Cardiology, Diabetes Management, Infectious Diseases, Oncology, Pediatrics 4) By Distribution Channel: Direct Sales, Distributors, Online Sales, Retail Pharmacies, Healthcare Institutions 5) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Laboratories, Emergency Medical Services (EMS) Subsegments: 1) By Diagnostic Devices: Blood Glucose Monitors, Hematology Analyzers, Coagulation Analyzers, Urinalysis Devices, Molecular Diagnostics 2) By Therapeutic Devices: Infusion Pumps, Respiratory Therapy Devices, Pain Management Devices, Wound Care Devices, Dialysis Devices 3) By Monitoring Devices: Vital Signs Monitors, Cardiac Monitors, Pulse Oximeters, Temperature Monitors, Respiratory Monitors 4) By Treatment Devices: Defibrillators, Surgical Devices, Laser Therapy Devices, Physical Therapy Devices 5) By Support Devices: Sample Collection Devices, Specimen Transport Devices, Data Management Devices, Calibration And Maintenance Devices

What Is The Driver Of The Point Of Care Devices Market?

The growing demand for diagnostic imaging is expected to propel the growth of the point-of-care devices market going forward. Diagnostic imaging refers to techniques and processes used to create visual representations of the interior of a body for clinical analysis and medical intervention. The demand for diagnostic imaging is increasing due to the rising prevalence of chronic diseases requiring early and accurate diagnosis. Point-of-care devices enhance diagnostic imaging by offering compact and mobile designs, making them ideal for clinics, bedside, and remote healthcare settings. They reduce turnaround time by providing rapid and accurate imaging results, improving clinical decision-making and patient care efficiency. For instance, in November 2024, according to the National Health Service, a UK-based government agency, in 2024, 47.2 million imaging tests were reported in England in the year to March, up 4.8% from 45.0 million recorded in the previous year. Therefore, the growing demand for diagnostic imaging is driving the growth of the point-of-care devices market.

Key Players In The Global Point Of Care Devices Market

Major companies operating in the point of care devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc., BioMérieux SA, Quidel Corporation, OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, Abaxis Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Chembio Diagnostics Inc., PTS Diagnostics LLC, MeMed, Alere Inc., Diagnostics For All Inc.

Global Point Of Care Devices Market Trends and Insights

Major companies operating in the point-of-care devices market are focusing on developing technologically advanced solutions, such as artificial intelligence-enhanced handheld ultrasound systems, to improve diagnostic accuracy and portability. Artificial intelligence-enhanced handheld ultrasound systems are portable imaging devices that use AI algorithms to assist in capturing and interpreting ultrasound images for faster and more accurate diagnoses. For instance, in October 2023, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, launched the Compact 5000 Series, an AI-enhanced point-of-care ultrasound system. This portable device offers superior image quality combined with advanced AI-driven automation for measurements and streamlined workflows, enabling fast and accurate diagnostics across various healthcare settings. It boasts user-friendly controls, supports multiple transducers, and integrates smoothly with telemedicine platforms to facilitate collaborative remote clinical care.

What Are Latest Mergers And Acquisitions In The Point Of Care Devices Market?

In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care technology platform from LumiraDx Limited for an undisclosed amount. With this acquisition, Roche aims to strengthen its position in the decentralized diagnostics space by integrating a user-friendly, portable platform capable of immunochemistry and clinical chemistry testing, with future potential for molecular diagnostics. LumiraDx Limited is a UK-based diagnostics company that offers point of care (PoC) devices.

Regional Outlook

North America was the largest region in the point of care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Point Of Care Devices Market?

The point of care devices market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, mobile health diagnostics, chronic disease screening, and real-time clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care devices market also includes sales of portable blood glucose meters, handheld immunoassay analyzers, rapid antigen test kits, mobile hematology analyzers, and compact molecular diagnostic devices. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.